Efficacy and prognosis of PD-1 inhibitors, trastuzumab, and first-line chemotherapy for HER-2-positive advanced gastric cancer in real-world study

被引：0
|
作者：
Liu, B. [1 ]
Tao, Y. [1 ]
Ke, Y. [1 ]
Rao, W. [1 ]
Liu, Q. [1 ]
机构：
[1] Nanjing Univ, Affiliated Drum Tower Hosp, Med Sch, Comprehens Canc Ctr, Nanjing, Peoples R China
来源：
ANNALS OF ONCOLOGY | 2024年 / 35卷
关键词：
D O I：
10.1016/j.annonc.2024.10.193
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
169P
引用
收藏
页码：S1470 / S1470
页数：1
相关论文
共 50 条
  • [41] Real-World Evidence of Trastuzumab, Pertuzumab, and Docetaxel Combination as a First-Line Treatment for Korean Patients with HER2-Positive Metastatic Breast Cancer
    Lee, Yong-Pyo
    Lee, Min-Sang
    Kim, HongSik
    Kim, Ji-Yeon
    Ahn, Jin Seok
    Im, Young-Hyuck
    Park, Yeon Hee
    CANCER RESEARCH AND TREATMENT, 2022, 54 (04): : 1130 - 1137
  • [42] Phase II Study of Bevacizumab in Combination with Trastuzumab and Capecitabine as First-Line Treatment for HER-2-positive Locally Recurrent or Metastatic Breast Cancer
    Martin, Miguel
    Makhson, Anatoly
    Gligorov, Joseph
    Lichinitser, Mikhail
    Lluch, Ana
    Semiglazov, Vladimir
    Scotto, Nana
    Mitchell, Lada
    Tjulandin, Sergei
    ONCOLOGIST, 2012, 17 (04): : 469 - 475
  • [43] First-line camrelizumab (a PD-1 inhibitor) plus apatinib (an VEGFR-2 inhibitor) and chemotherapy for advanced gastric cancer (SPACE): a phase 1 study
    Chen, Xiaofeng
    Xu, Hao
    Chen, Xiaobing
    Xu, Tongpeng
    Tian, Yitong
    Wang, Deqiang
    Guo, Fen
    Wang, Kangxin
    Jin, Guangfu
    Li, Xiao
    Wang, Rong
    Li, Fengyuan
    Ding, Yongbin
    Tang, Jie
    Fang, Yueyu
    Zhao, Jing
    Liu, Liang
    Ma, Ling
    Meng, Lijuan
    Hou, Zhiguo
    Zheng, Rongrong
    Liu, Yang
    Guan, Ni
    Zhang, Bei
    Tong, Shuang
    Chen, Shiqing
    Li, Xing
    Shu, Yongqian
    SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2024, 9 (01)
  • [44] First-line camrelizumab (a PD-1 inhibitor) plus apatinib (an VEGFR-2 inhibitor) and chemotherapy for advanced gastric cancer (SPACE): a phase 1 study
    Xiaofeng Chen
    Hao Xu
    Xiaobing Chen
    Tongpeng Xu
    Yitong Tian
    Deqiang Wang
    Fen Guo
    Kangxin Wang
    Guangfu Jin
    Xiao Li
    Rong Wang
    Fengyuan Li
    Yongbin Ding
    Jie Tang
    Yueyu Fang
    Jing Zhao
    Liang Liu
    Ling Ma
    Lijuan Meng
    Zhiguo Hou
    Rongrong Zheng
    Yang Liu
    Ni Guan
    Bei Zhang
    Shuang Tong
    Shiqing Chen
    Xing Li
    Yongqian Shu
    Signal Transduction and Targeted Therapy, 9
  • [45] Real-world Efficacy of PD-1/PD-L1 Inhibitors in Patients with Advanced Pulmonary Neuroendocrine Carcinoma
    Fan, Y.
    Yu, Y.
    Zhai, W.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) : S702 - S702
  • [46] A multicenter real-world study comparing the clinical equivalence of trastuzumab biosimilar HLX02 and reference trastuzumab in the treatment of HER-2-positive breast cancer
    Deng, Weishang
    Hu, Jia
    Yang, Sensen
    Xie, Zeyu
    Li, Mengting
    Li, Jinjian
    Zhuang, Wenbin
    Chen, Jisheng
    AMERICAN JOURNAL OF CANCER RESEARCH, 2023, 13 (07): : 3113 - 3122
  • [47] PD-1 inhibitors plus oxaliplatin or cisplatin-based chemotherapy in first-line treatments for advanced gastric cancer: A network meta-analysis
    Guo, Xiaoyu
    Yang, Bowen
    He, Lingzi
    Sun, Yiting
    Song, Yujia
    Qu, Xiujuan
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [48] Efficacy and safety of paclitaxel liposomes in combination with anti-HER-2 targeted drugs as first-line rescue therapy for HER-2-positive locally advanced or metastatic breast cancer: A retrospective, real-world study based on the Cancer Database of China National Cancer Center (NCC)
    Yue, J.
    Hui, Z.
    Ma, F.
    Zhang, J.
    Wang, S.
    Zhang, L.
    Zeng, X.
    Li, H.
    ANNALS OF ONCOLOGY, 2024, 35 : S1421 - S1421
  • [49] The real-world efficacy and safety of nivolumab plus chemotherapy in patients with HER2-negative advanced gastric cancer
    Liu, Yu-Yin
    Tsai, Ming-Yen
    Liu, Ting-Ting
    Liu, Yueh-Wei
    Lin, Yu-Hung
    Yeh, Cheng-Hsi
    Lin, Yu-Cheng
    Chen, Yen-Hao
    BMC CANCER, 2024, 24 (01)
  • [50] Efficacy and prognosis after neoadjuvant chemotherapy for HER2-positive breast cancers before and after trastuzumab era: a real-world study from China
    Song, Y.
    Lv, M.
    Wang, H.
    Mao, Y.
    Jiang, Z.
    BREAST, 2019, 44 : S67 - S68
12345